Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
20,54%
5-year Growth Rate
R
5/6
5-year Risk Analysis
O
-8,58%
Outlook 12/26
W
63,45%
Margin of safety
T
10,41%
Analyst Price Target
H
DOWN
50-week EMA Trend
Company Info
EPS Growth 5Y
20,65%
Revenue growth 5Y
20,44%
Price growth 5Y
14,50%
Market Cap
kr1.155,29 B
Long-Term Debt
kr110,37 B
Annual earnings
N/A
Dividend
kr11,85
Dividend Yield
4,55%
Industry
Country
Website
ISIN Number
Novo Nordisk A/S Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
kr287,50
10.41%
Last Update: 04/18/2026
Analysts: 22
Highest Price Target kr444,00
Average Price Target kr287,50
Lowest Price Target kr175,00
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Novo Nordisk A/S
CPSE:NOVO B
|
34,05% | 14,50% | 19,55% | 20,54% | 5/6 | -8,58% | 63,45% | 14,25% | DOWN |
